Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury

Journal of Trauma - Injury, Infection and Critical Care

Volumn 64, Issue 4, 2008, Pages 1069-1077

  Cairns, Bruce A ^a,b   Barnes, Carie M ^a   Mlot, Stefan ^a   Meyer, Anthony A ^a   Maile, Robert ^a,b  

^a North Carolina Jaycee Burn Center   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Burn injury; Cell death; Cytokines; Macrophages; Toll like receptors

Indexed keywords

CD11B ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BURN; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; SUPERNATANT;

ANIMALS; BURNS; CELL DEATH; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; IMMUNITY, NATURAL; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; PEPTIDOGLYCAN; RANDOM ALLOCATION; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPLEEN; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 42049123662     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318166b7d9     Document Type: Article

References (32)

1. Cioffi WG. What's new in burns and metabolism. J Am Coll Surg. 2001;192:241-244.
2. Tschoeke SK, Moldawer LL. Human leukocyte antigen expression in sepsis: what have we learned? Crit Care Med. 2005;33:236-237.
3. Wasserman D, Ioannovich JD, Hinzmann RD, Deichsel G, Steinmann GG. Interferon-gamma in the prevention of severe burn-related infections: a European phase III multicenter trial. The Severe Burns Study Group. Crit Care Med. 1998;26:434-439.
4. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987-995.
5. Xu D, Liu H, Komai-Koma M. Direct and indirect role of Toll-like receptors in T cell mediated immunity. Cell Mol Immunol. 2004;1:239-246.
6. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature. 2004;430:257-263.
7. Goldstein DR, Tesar BM, Akira S, Lakkis FG. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest. 2003;111:1571-1578.
8. Murphy TJ, Paterson HM, Mannick JA, Lederer JA. Injury, sepsis, and the regulation of Toll-like receptor responses. J Leukoc Biol. 2004;75:400-407.
9. Paterson HM, Murphy TJ, Purcell EJ, et al. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol. 2003;171:1473-1483.
10. Hunt JP, Hunter CT, Brownstein MR, et al. The effector component of the cytotoxic T-lymphocyte response has a biphasic pattern after burn injury. J Surg Res. 1998;80:243-251.
11. + T Cells is a mechanism for effective allogeneic skin graft rejection following burn injury. J Immunol. 2006;176:6717-6726.
12. Cairns BA, Maile R, Barnes CM, et al. Increased Toll-like receptor (TLR) 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury. J Trauma. 2006;61:293-298.
13. Noel JG, Guo X, Wells-Byrum D, Schwemberger S, Caldwell CC, Ogle CK. Effect of thermal injury on splenic myelopoiesis. Shock. 2005;23:115-122.
14. Cohen MJ, Carroll C, He LK, et al. Severity of burn injury and sepsis determines the cytokine responses of bone marrow progenitor-derived macrophages. J Trauma. 2007;62:858-867.
15. Silva KD, Gamelli RL, Shankar R. Bone marrow stem cell and progenitor response to injury. Wound Repair Regen. 2001;9:495-500.
16. Santangelo S, Gamelli RL, Shankar R. Myeloid commitment shifts toward monocytopoiesis after thermal injury and sepsis. Ann Surg. 2001;233:97-106.
17. + regulatory T cells that express toll-like receptors. J Exp Med. 2003;197:397-401.
18. Yanagawa Y, Onoe K. Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation. J Immunol. 2007;178:6173-6180.
19. Deitch EA. Spontaneous lymphocyte activity: an important but neglected component of the immunologic profile of the thermally injured patient. Surgery. 1985;98:587-593.
20. + regulatory T cells control innate immune reactivity after injury. J Immunol. 2005;174:2957-2963.
21. Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology. 2004;112:428-436.
22. Tuaillon N, Shen DF, Berger RB, Lu B, Rollins BJ, Chan CC. MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2002;43:1493-1498.
23. Soboll G, Schaefer TM, Wira CR. Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse. Am J Reprod Immunol. 2006;55:434-446.
24. Antoniazi S, Price HP, Kropf P, et al. Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major. Infect Immun. 2004;72:5168-5174.
25. Re F, Strominger JL. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol. 2004;173:7548-7555.
26. Jack CS, Arbour N, Manusow J, et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol. 2005;175:4320-4330.
27. Mueller T, Terada T, Rosenberg IM, Shibolet O, Podolsky DK. Th2 cytokines down-regulate TLR expression and function in human intestinal epithelial cells. J Immunol. 2006;176:5805-5814.
28. Gutierrez-Canas I, Juarranz Y, Santiago B, et al. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology (Oxford). 2006;45:527-532.
29. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol. 2005;5:446-458.
30. De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, Thomson AW. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol. 2005;174:2037-2045.
31. Knapp S, Gibot S, de Vos A, Versteeg HH, Colonna M, van der Poll T. Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol. 2004;173:7131-7134.
32. Alvarez JI. Inhibition of Toll like receptor immune responses by microbial pathogens. Front Biosci. 2005;10:582-587.